TABLE 4.

Linear regression of PROMIS EC sleep health (Sleep Disturbance) and MAPS-AR (Attention Dysregulation)

PROMIS EC Sleep (Sleep Disturbance)			MAPS-AR (Attention Dysregulation)
Variable	Unstandardized β value (95% CI)	p-Value	Variable	Unstandardized β value (95% CI)	p-Value
Model 1			Model 1
POEM w/o itch/sleep	1.22 [0.88 to 1.56]	<.01	POEM w/o itch/sleep	1.72 [1.24 to 2.203]	<.01
Model 2			Model 2
POEM w/o itch/sleep	1.01 [0.56 to 1.45]	<.01	POEM w/o itch/sleep	1.21 [0.57 to 1.85]	<.01
Itch severity	0.80 [−0.29 to 1.88]	.15	PROMIS EC Sleep	0.42 [−0.06 to −0.78]	.02
Model 3			Model 3
POEM w/o itch/sleep	0.79 [0.31 to 1.28]	<.01	POEM w/o itch/sleep	1.04 [0.33 to 1.75]	<.01
Itch severity	0.85 [−0.19 to 1.88]	.31	PROMIS EC Sleep Health	0.38 [0.20 to 0.75]	.04
Black	3.89 [0.49 to 7.28]	.03	Itch severity	0.80 [−0.71 to 2.31]	.29
Parental income	−1.05 [−2.20 to 0.10]	.07	Model 4
			POEM w/o itch/sleep	1.22 [0.51 to 1.93]	<.01
			Itch severity	0.86 [−0.56 to 2.29]	.23
			PROMIS EC Sleep	0.15 [−0.22 to 0.52]	.41
			Black	7.79 [3.01 to 12.58]	<.01
			Parental Income	−0.30 [−1.89 to 1.30]	.71

Note: Bold = statistically significant, p < .05.

Abbreviations: MAPS-AR, Multidimensional Assessment Profile of Attention Regulation; POEM, Patient-Oriented Eczema Measure; PROMIS, Patient-Reported Outcomes Measurement Information System.